rs1338086200
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP2
The NM_007175.8(ERLIN2):c.406G>A(p.Val136Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V136L) has been classified as Uncertain significance.
Frequency
Consequence
NM_007175.8 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 18Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
- juvenile primary lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- recessive intellectual disability-motor dysfunction-multiple joint contractures syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007175.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERLIN2 | NM_007175.8 | MANE Select | c.406G>A | p.Val136Ile | missense | Exon 6 of 12 | NP_009106.1 | ||
| ERLIN2 | NM_001362878.2 | c.406G>A | p.Val136Ile | missense | Exon 6 of 12 | NP_001349807.1 | |||
| ERLIN2 | NM_001003790.4 | c.406G>A | p.Val136Ile | missense | Exon 6 of 7 | NP_001003790.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERLIN2 | ENST00000519638.3 | TSL:2 MANE Select | c.406G>A | p.Val136Ile | missense | Exon 6 of 12 | ENSP00000428112.1 | ||
| ERLIN2 | ENST00000335171.10 | TSL:1 | c.406G>A | p.Val136Ile | missense | Exon 6 of 7 | ENSP00000335220.6 | ||
| ERLIN2 | ENST00000521644.5 | TSL:5 | c.406G>A | p.Val136Ile | missense | Exon 6 of 12 | ENSP00000429621.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251420 AF XY: 0.00000736 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 136 of the ERLIN2 protein (p.Val136Ile). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with ERLIN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 528006). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ERLIN2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary spastic paraplegia Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at